Back
Grand Canyon Education Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
58
LOPE
Grand Canyon Education
Last Price:
143.12
Seasonality Move:
0.36%
Buy
96
LBPH
Longboard Pharmaceuticals
Last Price:
31.81
Seasonality Move:
0.54%
Buy
58
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $141.13. The Score for LOPE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
96
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $30.74. The Score for LBPH is 96, which is 92% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $141.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOPE is experiencing slight selling pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $30.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing selling pressure, which indicates risk of future bearish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 55.61 | Buy |
| Chaikin Money Flow: | -14248 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (136.31 - 143.07) | Buy |
| Bollinger Bands (100): | (130.65 - 141.71) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 82.46 | Buy |
| Chaikin Money Flow: | -989705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.81 - 24.05) | Buy |
| Bollinger Bands (100): | (18.12 - 22.46) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.65 | Buy |
| 20-day SMA: | 138.88 | Buy |
| 50-day SMA: | 139.66 | Buy |
| 200-day SMA: | 131.96 | Buy |
| 8-day EMA: | 138.67 | Buy |
| 20-day EMA: | 138.88 | Buy |
| 50-day EMA: | 138.69 | Buy |
| 200-day EMA: | 131.22 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.23 | Buy |
| 20-day SMA: | 20.91 | Buy |
| 50-day SMA: | 20.5 | Buy |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 25.51 | Buy |
| 20-day EMA: | 22.42 | Buy |
| 50-day EMA: | 20.8 | Buy |
| 200-day EMA: | 16.41 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.86 per share, and an increase next year of $0.85 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.36 per share, and a decrease next year of $0.31 per share.
Grand Canyon Education Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||